Iclusig 15 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMDZ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,574
Award facts
- Contract value 100% obligated
- $58,573.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,573.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ICLUSIG 15 mg tablets (30-count units). The award, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $500 million ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a component of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to ensure consistent supply of branded and generic pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. ICLUSIG, a tyrosine kinase inhibitor used in oncology treatment, aligns with DMS Pharmaceutical Group's demonstrated capability in supplying specialized pharmaceutical products to support Department of Defense medical operations. The vendor's established performance on numerous prior delivery orders under the PPV-G GEN V framework and its registered small business status position it as a reliable supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMDZ0?
SPE2DR26FMDZ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FMDZ0 worth?
The government has obligated $58,574 on SPE2DR26FMDZ0.
Is contract SPE2DR26FMDZ0 an order under another contract?
Yes. SPE2DR26FMDZ0 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDZ0 competed?
The extent of competition for SPE2DR26FMDZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award